Internal Medicine, Rheumatology · Charlotte, NC
NPI
1659507747
Since 2009
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 Blythe Blvd
Charlotte, NC, 28203
Phone (704) 446-1242
Groups this clinician bills Medicare through
Medicare paid, 2024
$966K
62,990 services
Medicare patients, 2024
207
Average age 74
Drug cost, 2024
$895K
1,537 prescriptions
Company payments, 2025
$45.73
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Morgan was code Q5104 (injection, infliximab-abda, biosimilar, (renflexis), 10 mg), 3,885 times for 11 patients. In total Michael Morgan billed 62,990 services in 45 codes, and Medicare paid $966K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 3,885 | 11 | $23.28 | $90K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,383 | 14 | $24.88 | $84K |
| J0897 Injection, denosumab, 1 mg | Office | 2,880 | 28 | $20.16 | $58K |
| 99214 Office E&M - Established | Office | 469 | 181 | $82.80 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 242 | 127 | $11.70 | $2,832 |
| 36415 Venipuncture Blood Collection | Office | 188 | 104 | $7.71 | $1,450 |
| 96413 Chemotherapy Administration | Office | 183 | 38 | $82.56 | $15K |
| 96365 Intravenous Infusion, Hydration | Office | 145 | 19 | $43.52 | $6,310 |
| 96415 Chemotherapy Administration | Office | 88 | 26 | $17.91 | $1,576 |
| 96372 Injection Administration | Office | 64 | 31 | $9.74 | $623 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 55 | 11 | $5.19 | $285 |
| 96375 Injection Administration | Office | 40 | 13 | $9.65 | $386 |
| 99215 Office E&M - Established | Office | 28 | 21 | $129.83 | $3,635 |
| G0008 Administration of influenza virus vaccine | Office | 25 | 24 | $30.87 | $772 |
| 90662 Vaccine Product | Office | 22 | 22 | $81.82 | $1,800 |
By year: 2022 $916K for 55,041 services; 2023 $912K for 60,933 services; 2024 $966K for 62,990 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 188 | 104 | $7.71 | $1,450 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Morgan prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 354 prescriptions and refills. In total Michael Morgan wrote 1,537 Medicare prescriptions that cost $895K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 354 | 961 | 114 | $13K |
| Hydroxychloroquine Sulfate Generic | 175 | 496 | 56 | $11K |
| Prednisone Generic | 123 | 257 | 47 | $1,266 |
| Folic Acid Generic | 89 | 264 | 26 | $902 |
| Celecoxib Generic | 66 | 165 | 19 | $2,763 |
| Alendronate Sodium Generic | 47 | 132 | 16 | $309 |
| Meloxicam Generic | 46 | 122 | 15 | $469 |
| Sulfasalazine Generic | 46 | 86 | 12 | $1,412 |
| Leflunomide Generic | 35 | 101 | 12 | $1,511 |
| Enbrel Sureclick Etanercept | 31 | 45 | Under 11 | $343K |
| Allopurinol Generic | 31 | 92 | Under 11 | $380 |
| Colchicine Generic | 30 | 64 | 14 | $1,908 |
| Pilocarpine Hcl Generic | 28 | 51 | 11 | $2,274 |
| Gabapentin Generic | 26 | 49 | Under 11 | $489 |
| Cevimeline Hcl Generic | 23 | 62 | Under 11 | $5,755 |
Brand drugs: - claims; generic drugs: 1,271 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Morgan $45.73 ($45.73 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $45.73.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $45.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.